- Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely and Jones; 1817.
- Caplan, Jacobson, Rubinstein, Rotman Megacolon and volvulus in Parkinson's disease. 1965; 85: 73-8Radiology
- Eadie MJ, Tyrcr JH. Alimentary disorder in parkinsonism. Australas Ann Med 1965;14:13-22.
- Edwards L, Quigley EMM, Hofinan R, Pfeiffer RF. Gastrointestinal symptoms in Parkinson Disease: 18-month follow-up study. Mov Disord 1993;8:83-6.
- Edwards, Quigley, Harned, Hofman, Pfeiffer Characterization of swallowing and defecation in Parkinson's disease. 1994; 89: 15-25Am J Gastroenterol
- Korczyn Autonomic nervous system disturbances in Parkinson's disease. 1990; 53: 463-8Adv Neurol
- Jost, Schimrigk Constipation in Parkinson's disease. 1991; 69: 906-9Klin Wochenschr
- Wang, Fuh, Shan, Liao, Lin, Tsai Sympathetic skin response and R-R interval variation in Parkinson's disease. 1993; 8: 151-7Mov Disord
- Sakakibara, Shinotoh, Uchiyama, Sakuma, Kashiwado, Yoshiyama Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. 2001; 92: 76-85Auton Neurosci
- Kuroiwa Y, Shimada Y, Toyokura Y. Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology 1983; 33: 463-7.
- Edwards, Pfeiffer, Quigley, Hofman, Balluff Gastrointestinal symptoms in Parkinson's disease. 1991; 6: 151-6Mov Disord
- Pallis CA. Parkinsonism: natural history and clinical features. Br Med J 1971:3:683-90.
- Singer, Weiner, Sanchez-Ramos Autonomic dysfunction in men with Parkinson's disease. 1992; 32: 134-40Eur Neurol
- Kuroiwa Y, Wada T, Tohgj H. Measurement of blood pressure and heart-rate variation while resting supine and standing for the evaluation of autonomie dysfunction. J Neurol 1987;235:65-8.
- Porter RW, Bors E. Neurogenic bladder in parkinsonism: effect of thalamotomy. J Neurosurg 1971;34:27-32.
- Jost WH, Schrank B. Defecatory disorders in de novo Parkinsonians: colonie transit and electromyogram of the external anal sphincter. Wiener Klin Wschr 1998;110:535-7.
- Bassotti, Maggio, Battaglia, Giulietti, Spinozzi, Reboldi Manometric investigation of anorectal function in early and late stage Parkinson's disease. 2000; 68: 768-70J Neurol Neurosurg Psychiatry
- Ashraf, Pfeiffer, Park, Lof, Quigley Constipation in Parkinson's disease: objective assessment and response to psyllium. 1997; 12: 946-51Mov Disord
- Abbott, Petrovitch, White, Masaki, Tanner, Curb Frequency of bowel movements and the risk of Parkinson's disease. 2001; 57: 456-62Neurology
- Stocchi, Badiali, Vacca, D'Alba, Bracci, Ruggieri Anorectal function in multiple system atrophy and Parkinson's disease. 2000; 15: 71-6Mov Disord
- Jost, Jung, Schimrigk Colonic transit in non-idiopathic Parkinson's syndrome. 1994; 34: 329-31Eur Neurol
- Herm, Jordan, Jost, Pfennig, Arnold Colontransitzeit bei neuromuskulären Erkrankungen vor und nach Colonreflexmassagen. 1995; 90: 199Med Klinik
- Harari D, Gurwitz JH, Avorn J, Bohn R, Minaker KL. Bowel habit in relation to age and gender: findings from the National Health Interview Survey and Clinical Implications. Arch Intern Med 1996;156:315-20.
- Bingham JR, Ingelfinger FJ, Smithwick RH. The effects of sympathectomy on the motility of the human gastrointestinal and biliary tracts. Gastroenterology 1950;15:16-7.
- Lewitan A, Nathanson L, Slade WR. Megacolon and dilatation of the small bowel in parkinsonism. Gastroenterology 1951;17: 367-74.
- Klaue Parkinsonsche Krankheit (Paralysis agitans) und postencephalitischer Parkinsonismus. 1940; 111: 251-321Archiv für Psychiatrie
- Kuroiwa Y, Shimada Y, Toyokura Y. Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology 1983; 33: 463-7.
- Schwab, England Parkinson's disease. 1958; 8: 488-509J Chron Dis
- Calne DB, Brennan J, Spiers ASY, Stern GM. Hypotension caused by L-dopa. Br Med J 1970;l:474-5.
- Mesec, Šega, Kiauta The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic responses. 1993; 3: 339-44Clin Autonom Res
- Turkka, Juujärvi, Lapinlampi, Myllylä Serum noradrenaline response to standing up in patients with Parkinson's disease. 1986; 25: 355-61Eur Neurol
- Braak, Del Tredici, Bratzke, Hamm-Clement, Sandmann-Keil, Rüb Staging to the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease. 2002; 249 Suppl 3: 1-5J Neurol
- Del Tredici, Rüb, de Vos, Bohl, Braak Where does Parkinson disease pathology begin in the brain? 2002; 61: 413-26J Neuropathol Exp Neurol
- Neundörfer Risiken und Nebenwirkungen der medikamentösen Therapie. 1992; 11: 63-7Nervenheilkunde
- Siegmund Anatomisch nachgewiesene Folgen von Tonus- und Motilitätsstörungen des Verdauungskanals bei Enzephalitikern, die mit Atropin behandelt wurden. 1935; 82: 453-4MMW
- Den Hartog Jager Sphingomyelin in Lewy inclusion bodies in Parkinson's disease. 1969; 21: 615-9Arch Neurol
- Forno The Lewy body in Parkinson's disease. 1986; 45: 35-43Adv Neurol
- Kupsky, Grimes, Sweeting, Bertsch, Cote Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. 1987; 37: 1253-5Neurology
- Ohama, Ikuta Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. 1976; 34: 311-9Acta Neuropathol
- Qualman, Haupt, Yang, Hamilton Esophageal Lewy bodies associated with ganglion cell loss in achalasia: similarity to Parkinson's disease. 1984; 87: 848-56Gastroenterology
- Wakabayashi, Takahashi, Ohama, Takeda, Ikuta Lewy bodies in the visceral autonomic nervous system in Parkinson's disease. 1993; 60: 609-12Adv Neurol
- Den Hartog Jager WA, Bethlem J. The distribution of Lewy bodies in the central and autonomie nervous system in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 1960;23:28390.
- Eadie MJ. The pathology of certain medullary nuclei in parkinsonism. Brain 1963;86:781-92.
- Oyanagi, Wakabayashi, Ohama, Takeda, Horikawa, Morita Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson's disease. 1990; 80: 558-9Acta Neuropathol
- Singaram, Ashraf, Gaumintz, Torbey, Sengupta, Pfeiffer Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. 1995; 346: 861-4Lancet
- Wakabayashi, Takahashi, Takeda, Ohama, Ikuta Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. 1988; 76: 217-21Acta Neuropathol
- Mitolo-Chieppa D, Mansi G, Rinaldi R, Montagnani M, Potenza MA, Genualdo M, et al. Cholinergjc stimulation and nonadrenergjc, noncholinergic relaxation of human colonie circular muscle in idiopathic chronic constipation. Dig Dis Sci 1998;43: 2719-26.
- Mathers, Kempster, Law, Frankel, Bartram, Lees Anal sphincter dysfunction in Parkinson's disease. 1989; 46: 1061-4Arch Neurol
- Ashraf, Pfeiffer, Quigley Anorectal manometry in the assessment of anorectal function in Parkinson's disease: a comparison with chronic idiopathic constipation. 1994; 9: 655-63Mov Disord
- Jost, Schrank, Herold, Leiß Functional outlet obstruction: anismus, spastic pelvic floor syndrome, and dyscoordination of the voluntary sphincter muscles. 1999; 34: 449-53Scand J Gastroenterol
- Mathers, Kempster, Swash, Lees Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon? 1988; 51: 1503-7J Neurol Neurosurg Psychiatry
- lost WH, Schimrigk K. Bestimmung der Kolontransitzeit beim Parkinson-Syndrom. Akt Neurol 1992;19:52-3.
- Eardley I, Quinn NP, Fowler CJ, Kirby RS, Parkhouse HF, Marsden CD, et al. The value of urethra! sphincter electromyography in the differential diagnosis of parkinsonism. Br J Urol 1989;64:360-2.
- Jost WH, Schimrigk K. Elektromyogramm des M. sphincter ani extemus beim idiopathischen Parkinson Syndrom. Akt Neurol 1996;23:167-70.
- Astarloa, Mena, Sanchez, de la Vega, de Yebenes Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson's disease. 1992; 15: 375-80Clin Neuropharmacol
- Jost, Schimrigk Cisapride treatment of constipation in Parkinson's disease. 1993; 8: 339-43Mov Disord
- Djaldetti, Koren, Achiron, Melamed Effect of cisapride on response fluctuations in Parkinson's disease. 1995; 10: 81-4Mov Disord
- Neira, Sanchez, Mena, de Yebenes The effects of cisapride on plasma L-dopa levels and response in Parkinson's disease. 1995; 10: 66-70Mov Disord
- Jost, Schimrigk Long-term results with cisapride in Parkinson's disease. 1997; 12: 423-6Mov Disord
- Task force Management of Parkinson's disease: an evidence-based review. Drugs to treat autonomic dysfunction in Parkinson's disease. 2002; 17 Suppl 4: S103-11Mov Disord
- Parkes Domperidone and Parkinson's disease. 1986; 9: 517-32Clin Neuropharmacol
- Paulseth, Jensen, Klawans Domperidone therapy in patients with Parkinson's disease with levodopa-carbidopa-related gastrointestinal complaints. 1984; 16: 127-8Ann Neurol
- Soykan, Sarosiek, Shifflett, Wooten, McCallum Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease. 1997; 12: 952-7Mov Disord
- Rutgeerts P, Vantrappen G, Hiele M, Ghoos Y, Onkellin C. Effects on bowel motility of misoprostol administered before and after meals. Aliment Pharmacol Ther 1991;5:533-42.
- Delvaux M, Staumont G, Fioramonti J, Bueno L, Frexinos J. Alterations of colonie motility after oral administration of prostaglandin El analogue misoprostol in man. J Gastrointest Motil 1992;4:33-8.
- Soffer EE, Metcalf A, Launspach J. Misoprostol is effective treatment for patients with severe chronic constipation. Dig Dis Sei 1994;39:929-33.
- Roarty TP, Weber F, Soykan I, McCallum RW. Misoprostol in the treatment of chronic refrectory constipation: results of a long-term open label trial. Aliment Pharmacol Ther 1997; 11: 1059-66.
- Baker DE. Tegaserod for the treatment of constipationpredominant irritable bowel syndrome. Rev Gastroenterol Disord 2001;1:187-98.
- A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF Study Group (phase III). 1999; 52: 1427-33Neurology
- Coulie B, Szarka LA, Camilleri M, Burton DD, McKinzie S, Stambler N, et al. Recombinant human neurotrophic factors accelerate colonie transit and relieve constipation in humans. Gastroenterology 2000;119:41-50.
- Edwards, Quigley, Harned, Hofman, Pfeiffer Defecatory function in Parkinson's disease: response to apomorphine. 1993; 33: 490-3Ann Neurol
- Cleveland MV, Flavin DP, Ruben RA, Epstein RM, Clark GE. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. South Med J 2001;94:478-81.
- Di Palma JA, Smith JR, Cleveland M. Overnight efficacy of polyethylene glycol laxative. Am J Gastroenterol 2002; 97: 1776-9.
- Eichhorn, Oertel Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multi system atrophy. 2001; 16: 1176-7Mov Disord
- Albanese, Maria, Bentivoglio, Brisinda, Cassetta, Tonali Severe constipation in Parkinson's disease relieved by botulinum toxin. 1997; 12: 764-6Mov Disord
- Winge K, Rasmussen D, Werdelin LM. Constipation in neurological diseases. J Neurol Neurosurg Psychiatry 2003 ;74: 13-19.
- Quigley Gastrointestinal dysfunction in Parkinson's disease. 1996; 16: 245-50Semin Neurol
Scandinavian Journal of Gastroenterology
Volume 38, 2003 - Issue 7